Moderate coffee and caffeine consumption may play a significant role in preventing cardiometabolic multimorbidity, which includes serious conditions like type 2 diabetes, coronary heart disease, and stroke. A recent study analyzed data from over 360,000 participants in the UK Biobank, revealing that those who consumed 200 to 300 mg of caffeine daily had a notably lower risk of developing these diseases.
• Participants who drank three cups of coffee daily had a 48.1% reduced risk for new-onset cardiometabolic diseases.
• Those consuming less than 100 mg of caffeine showed a much higher risk.
• The study highlights the importance of moderate caffeine intake for health benefits.
• However, excessive caffeine can lead to negative effects like insomnia and increased blood pressure.
Understanding the balance of caffeine's benefits and risks is crucial. As more people seek ways to enhance their health, promoting moderate caffeine consumption could lead to significant public health benefits. This study adds to the growing evidence that dietary habits can impact long-term health outcomes.
Enjoying the read? Subscribe for free to one of the fastest-growing newsletters and get weekly coffee news (TL;DR updates) delivered right to your inbox.